Dose: 0.238 to 0.714 mg/kg
Single Dose: 0.48 (0.476)
Frequency: 8 hourly
Route: PO
Instructions: -

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

. It is of Natural origin and belongs to Benzodiazepine. It belongs to Cholinergic muscarinic antagonist pharmacological group on the basis of mechanism of action and also classified in Gastrointestinal Anticholinergics/Antispasmodics and Antipeptic Ulcerant pharmacological group.The Molecular Weight of Pirenzepine (di HCl) is 424.30. Its pKa is 2.1, 8.1.

Pirenzepine (di HCl) is contraindicated in conditions like Renal failure.

The signs and symptoms that are produced after the acute overdosage of Pirenzepine (di HCl) include Anticholinergic effects.The symptomatic adverse reactions produced by Pirenzepine (di HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dry mouth, Disturbances of accomodation.

Pirenzepine (di HCl) is primarily indicated in conditions like Benign gastric ulcer, Duodenal ulcer.

No data regarding the interactions of Pirenzepine (di HCl) was found.

Drug should not be given to Paediatrics, Pregnant Mothers, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Protect from Moisture.

Pirenzepine should be used with caution in patients with renal (kidney) impairment, particularly those with end-stage renal failure. Avoid use in patients with angle closure glaucoma.